LEONARD ZON received the 20th annual Alfred G. Knudson Award in Cancer Genetics from the NCI.
Eisai submitted a Marketing Authorization Application to the European Medicines Agency for the use of lenvatinib in combination with everolimus to treat people with unresectable advanced or metastatic renal cell carcinoma who have received one prior vascular endothelial growth factor-targeted therapy.
THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY published a set of recommendations aimed to promote the reproducibility and transparency of biomedical and biological research.
Sorrento Therapeutics Inc. formed a partnership with the Karolinska Institutet in Stockholm, Sweden, to perform immuno-oncology research and to develop new natural killer cell-based therapies.
The Campaign for Tobacco-Free Kids said the U.S. Chamber of Commerce is undeserving of its Gold Standard accreditation by the CEO Roundtable on Cancer, saying it should be rescinded because of the trade group's lobbying efforts against tobacco regulations.
RAVI SALGIA joined City of Hope as a professor and chair of the Department of Medical Oncology & Therapeutics Research.
The U.S. Preventive Services Task Force published its final recommendation statement on screening for breast cancer, delivering a B rating for mammography screening every two years in women between ages 50 and 74.
RAFAT ABONOUR was appointed medical liaison for the International Myeloma Foundation, to support the group's European program expansion.
DEAN TSARWHAS was named medical director of cancer services for Northwestern Medicine's Lake Forest Hospital and Grayslake Outpatient Center. Previously, Tsarwhas treated oncology patients in private practice. He has also been on staff at Lake Forest Hospital.
PAUL KLUETZ was appointed associate director of clinical science in the FDA Office of Hematology Oncology Products, effective Jan. 24.
